Mikos is the John W. Cox Professor of Bioengineering, professor of chemical engineering and director of the John W. Cox Laboratory for Biomedical Engineering at Rice. In addition, he also serves as director of Rice's Center for Excellence in Tissue Engineering.
The Urist Award was established in 1996 and is sponsored by Osiris Therapeutics, Inc. It is given annually to one researcher who has established a reputation as a cutting-edge researcher in tissue regeneration. The award includes a $5,000 prize.
Mikos will receive the award at the society's annual meeting next month in Washington, D.C.
"This prestigious award reflects the hard work of past and present undergraduate, graduate, and post-doctoral research associates in my group over the years," said Mikos.
Over the past 13 years, Mikos' laboratory has developed extensive expertise in fabricating synthetic materials with tailored chemistries for specific tissue-engineered repair of orthopaedic injuries.
For example, Mikos and his associates have created several novel materials based on fumaric acid, a natural product found in mammalian cell metabolism. The new materials are non-toxic to surrounding cells and tissues, and they degrade over time into products that are excreted from the body. When used as surgically implanted scaffolds, these materials act as a template, guiding the body's cells as they form new tissue to replace flesh or bone that's been lost to disease or injury. Since the scaffolds break down naturally, no further surgery is needed to remove them once they are implanted.
Mikos lab has also developed techniques for growing new bone and cartilage tissue by seeding the scaffolds with cells. Because the Mikos group's scaffolds are highly porous and contain a large surface area, they allow seeded cells to receive nutrients from the body while the new tissue forms, thus overcoming one of the major roadblocks to tissue engineering.
In addition, Mikos and his associates are developing non-surgical approaches for scaffold implantation. In this case, the scaffold material is injected as a liquid at the site of an injury, and it is exposed to light or other chemicals that cause it to harden within a few minutes. Once the material sets, it acts as an immediate aid in the body's efforts to form new tissue and heal itself.
In developing its scaffolding materials, Mikos' group has focused on chemical modifications that control material properties like stiffness as well as the function of seeded cells. They've accumulated strong experimental evidence that show their methods can be used to tailor implanted materials to attract certain cell types and direct their migration and differentiation to aid in the regeneration of specific tissues in desired areas.
Recently, the Mikos laboratory has been working on composite materials that support and guide developing tissues through the controlled release of bioactive molecules, and they are investigating nano-structured materials that can enhance the strength and load-bearing properties of scaffolds for orthopaedic applications. They are also developing new fumaric acid-based polymeric carriers for targeted delivery of signaling molecules including peptides, proteins, and plasmid DNA.
A pioneer in the field of tissue engineering, Mikos is a founding editor of the journal Tissue Engineering and member of the editorial boards of the journals Biomaterials, Advanced Drug Delivery Reviews, Cell Transplantation, Journal of Biomaterials Science Polymer Edition, Journal of Biomedical Materials Research, and Journal of Controlled Release. He is also the organizer of the continuing education course Advances in Tissue Engineering offered annually at Rice since 1993.
Founded in 1954, the 1,700-member Orthopaedic Research Society is dedicated to improving patient care through research and education in orthopaedic surgery, musculoskeletal diseases, musculoskeletal injuries and related disciplines.